GL1X · GenesisL1 explorer

MolNFT v1 · #163087 · protein

Structure based optimization of JAK1-ATP binding pocket inhibitors in the aminopyrazole class

6RSE · Tyrosine-protein kinase JAK1: “Structure based optimization of JAK1-ATP binding pocket inhibitors in the aminopyrazole class”. X-ray diffraction, 1 ligand (KHH), 5 pockets (best druggability 0.74). MolNFT v1 #163087 on GenesisL1: 3D…

PDB
6RSE
Type
protein
Length
567 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK1
EC
2.7.10.2
UniProt
P23458
Ligands
KHH
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK1 (EC 2.7.10.2)protein28643% helix, 21% strandP23458
BTyrosine-protein kinase JAK1 (EC 2.7.10.2)protein28143% helix, 21% strandP23458

Ligands and binding sites

  • KHH · methyl ~{N}-[4-aminocarbonyl-1-[(3~{R},4~{R})-4-(cyanomethyl)-1-[(4-ethenyl-2-fluoranyl-5-oxidanyl-phenyl)methyl]-3-fluoranyl-piperidin-4-yl]pyrazol-3-yl]carbamate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16520.740.8165KHH
25580.740.8258KHH
3790.470.8222empty
4600.440.8320empty
5550.290.7516empty

Interfaces

1 interface between chains.

  • A–B · 880 Ų buried · 17 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 6RSE · Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.